FDA Expands AI Capabilities and Completes Data Platform Consolidation
Elsa 4.0 adds custom agents, document generation and voice dictation as the agency expands AI tools for all FDA staff.
7 Articles
7 Articles
FDA Expands AI Tools, Launches Unified Data Platform
The U.S. Food and Drug Administration announced new steps to modernize its operations, including the rollout of an upgraded artificial intelligence system and the consolidation of agency data into a single platform. The agency said it has launched Elsa 4.0, the latest version of its internal AI tool, which is now available to staff across the organization, from scientific reviewers to investigators. Officials said the update is designed to strea…
FDA Expands AI Capabilities and Completes Data Platform Consolidation
White Oak, Md., May 06, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced major steps in its bold initiative to modernize the agency. The agency launched Elsa 4.0, a significant upgrade to the agency's internal AI tool available to all FDA staff, from scientific reviewers to investigators. The agency also consolidated more than 40 disparate application and submission data sources, systems and portals across all FDA…
FDA launches updated AI and consolidated data platform
The Food and Drug Administration announced on Wednesday that it has launched an updated version of its internal artificial intelligence tool, called Elsa, that is being integrated with a consolidated data platform to enable faster search capabilities. Elsa 4.0 now features expanded access to disparate agency information within a new consolidated data platform, called the Harmonized AI & Lifecycle Operations for Data. By merging HALO and Elsa, st…
FDA Launches Elsa 4.0, Consolidates Data Systems
The Food and Drug Administration has launched Elsa 4.0, the latest version of its internal artificial intelligence platform, and consolidated more than 40 agency application and submission systems into a new data platform called HALO. The agency said Wednesday the modernization effort is intended to expand AI integration across FDA operations and improve how staff access and analyze regulatory data. “Integrating AI into our workflows is an urgen…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
